FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 345:1337-1340 November 1, 2001 Number 18 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Vasan, R. S. PubMed Citation

On the basis of evidence from multiple clinical trials, it is recommended that antihypertensive therapy be instituted for patients with confirmed hypertension — that is, when the systolic blood pressure exceeds 140 mm Hg or the diastolic blood pressure exceeds 90 mm Hg.¹ However, many patients who have a myocardial infarction, stroke, or other cardiovascular event have blood pressures below these thresholds. In fact, it is recognized that cardiovascular risk increases linearly at blood-pressure levels lower than those that usually trigger the use of antihypertensive therapy — specifically at a systolic pressure of 130 to 135 mm Hg and a . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Oparil, S., Zaman, M. A., Calhoun, D. A. (2003). Pathogenesis of Hypertension. ANN INTERN MED 139: 761-776 [Full Text]  
• Gomez-Cerezo, J., Rios Blanco, J. J., Suarez Garcia, I., Moreno Anaya, P., Garcia Raya, P., Vazquez-Munoz, E., Barbado Hernandez, F. J. (2002). Noninvasive Study of Endothelial Function in White Coat Hypertension. Hypertension 40: 304-309 [Abstract] [Full Text]  
• O'Rourke, M. (2002). Target organ damage: use of pulse wave analysis as a manifestation of aortic degeneration in the assessment of hypertension. Vasc Med 7: 83-85